EvoNext Holdings SA (SWX:EVE)
Switzerland · Delayed Price · Currency is CHF 0.9000
+0.0280 (3.21%)
Mar 13, 2026, 4:02 PM CET
EvoNext Holdings Market Cap
EvoNext Holdings has a market cap or net worth of 6.29 million as of March 13, 2026. Its market cap has decreased by -29.68% in one year.
Market Cap
6.29M
Enterprise Value
-24.53K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.90
Market Cap Chart
Since March 1, 2010, EvoNext Holdings's market cap has decreased from 392.12M to 6.29M, a decrease of -98.40%. That is a compound annual growth rate of -22.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 6.35M | 8.64% |
| Dec 30, 2025 | 5.84M | -10.00% |
| Dec 30, 2024 | 6.49M | 32.37% |
| Dec 29, 2023 | 4.90M | -94.61% |
| Dec 30, 2022 | 91.05M | -28.31% |
| Dec 30, 2021 | 127.00M | -19.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 978.36M |
| Basilea Pharmaceutica AG | 649.00M |
| Newron Pharmaceuticals | 363.28M |
| Santhera Pharmaceuticals Holding AG | 237.31M |
| Xlife Sciences AG | 140.73M |
| Molecular Partners AG | 140.25M |
| BioVersys AG | 135.09M |
| Addex Therapeutics | 5.25M |